Want to join the conversation?
$BMY said that Opdivo has been approved in 50 countries and international sales in 1Q16 were $110MM. The company said that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for the Opdivo-Yervoy regimen in melanoma.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.